GlycoSyn is the discovery, development and GMP manufacturing arm of Industrial Research Limited (IRL). GlycoSyn was established in 2003 to complement an existing and successful drug discovery platform with downstream process development, as well as non-GMP and GMP manufacture of active pharmaceutical ingredients (APIs). GlycoSyn has successfully delivered development and manufacturing services to international clients involving API’s ranging in nature from flat earth small molecules to dendrimers and complex oligosaccharides. GlycoSyn provides synthetic route evaluation and development, process development, kilogram scale non-GMP production and GMP manufacture of a variety of investigational new drugs under contract to global pharmaceutical companies. GlycoSyn has unmatched expertise in carbohydrate chemistry and multi-step chemical synthesis. Together with its partner Mimotopes they also offer custom synthesized peptide therapeutic candidates.